Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6Prostatic Neoplasms 3Multiple Myeloma 3Colorectal Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Rectal Neoplasms 2Neoplasms, Plasma Cell 2Neoplasms 2Melanoma 2Glioblastoma 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Solid Tumor 1Sarcoma, Clear Cell 1Refractory or Relapsed Solid Tumors 1Platinum-resistant Epithelial Ovarian Cancer 1Neoplasm Metastasis 1Malignant Solid Tumour 1Lymphangioleiomyomatosis 1Lung Neoplasms 1Liver Neoplasms 1Klatskin Tumor 1Gliosarcoma 1Gastrointestinal Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Arthritis, Rheumatoid 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Fluorouracil 2Capecitabine 2tremelimumab 1trametinib 1temoporfin 1durvalumab 1dehydroftorafur 1Sorafenib 1Self Expandable Metallic Stents 1Radiosurgery 1Platinum 1Oxaliplatin 1N-Ac-CHAVC-NH2 1Leucovorin 1Hydroxychloroquine 1Gemcitabine 1Erlotinib Hydrochloride 1Cisplatin 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Klatskin Tumor × Hydroxychloroquine × Clear all
NCT03377179 2025-07-23

A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma

RedHill Biopharma Limited

Phase 2 Completed
65 enrolled
Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡